Developing COPD: a 25 Year Follow Up Study of the General Population

Overview

Journal Thorax

Date 2006 Oct 31

PMID 17071833

Citations 221

Authors

A Lokke

P Lange

H Scharling

P Fabricius

J Vestbo

Affiliations

Soon will be listed here.

Abstract

Background: Smokers are more prone to develop chronic obstructive pulmonary disease (COPD) than non-smokers, but this finding comes from studies spanning 10 years or less. The aim of this study was to determine the 25 year absolute risk of developing COPD in men and women from the general population.

Methods: As part of the Copenhagen City Heart Study, 8045 men and women aged 30-60 years with normal lung function at baseline were followed for 25 years. Lung function measurements were collected and mortality from COPD during the 25 year observation period was analysed.

Results: The percentage of men with normal lung function ranged from 96% of never smokers to 59% of continuous smokers; for women the proportions were 91% and 69%, respectively. The 25 year incidence of moderate and severe COPD was 20.7% and 3.6%, respectively, with no apparent difference between men and women. Smoking cessation, especially early in the follow up period, decreased the risk of developing COPD substantially compared with continuous smoking. During the follow up period there were 2912 deaths, 109 of which were from COPD. 92% of the COPD deaths occurred in subjects who were current smokers at the beginning of the follow up period.

Conclusion: The absolute risk of developing COPD among continuous smokers is at least 25%, which is larger than was previously estimated.

Citing Articles

Risk Factors of FEV₁/FVC Decline in COPD Patients.

Kim N, Kim D, Park S, Hwang Y, Seo H, Park D J Korean Med Sci. 2025; 40(6):e32.

PMID: 39962940 PMC: 11832881. DOI: 10.3346/jkms.2025.40.e32.

Comparison of respiratory symptoms and pulmonary functions of adult male cigarette smokers and non-smokers in Sri Lanka; A comparative analytical study.

Herath P, Wimalasekera S, Amarasekara T, Fernando M, Turale S PLoS One. 2025; 20(2):e0315095.

PMID: 39937707 PMC: 11819500. DOI: 10.1371/journal.pone.0315095.

Association of chronic obstructive pulmonary disease with risk of lung cancer in individuals aged 40 years and older: A cross-sectional study based on NHANES 2013-2018.

Chen H, Hu X, Zhou J, He C, Wang K, Yi Q PLoS One. 2024; 19(10):e0311537.

PMID: 39441785 PMC: 11498685. DOI: 10.1371/journal.pone.0311537.

Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO).

Lai Y, Tsai Y, Hsieh M, Chen N, Cheng S, Tao C Respir Res. 2024; 25(1):377.

PMID: 39420386 PMC: 11487693. DOI: 10.1186/s12931-024-02971-3.

Breathing new life into the study of COPD with genes identified from genome-wide association studies.

Werder R, Zhou X, Cho M, Wilson A Eur Respir Rev. 2024; 33(172).

PMID: 38811034 PMC: 11134200. DOI: 10.1183/16000617.0019-2024.

References

Pauwels R, Rabe K . Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004; 364(9434):613-20. DOI: 10.1016/S0140-6736(04)16855-4. View

Rennard S, Vestbo J . COPD: the dangerous underestimate of 15%. Lancet. 2006; 367(9518):1216-9. DOI: 10.1016/S0140-6736(06)68516-4. View

Burrows B, KNUDSON R, Camilli A, Lyle S, LEBOWITZ M . The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis. 1987; 135(4):788-93. DOI: 10.1164/arrd.1987.135.4.788. View

Camilli A, Burrows B, KNUDSON R, Lyle S, LEBOWITZ M . Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis. 1987; 135(4):794-9. DOI: 10.1164/arrd.1987.135.4.794. View

Tager I, Segal M, Speizer F, Weiss S . The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. Am Rev Respir Dis. 1988; 138(4):837-49. DOI: 10.1164/ajrccm/138.4.837. View

Lange P, Groth S, Nyboe G, Mortensen J, Appleyard M, Jensen G . Effects of smoking and changes in smoking habits on the decline of FEV1. Eur Respir J. 1989; 2(9):811-6. View

Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M . Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J. 1991; 4(9):1080-7. View

Lange P . Development and prognosis of chronic obstructive pulmonary disease with special reference to the role of tobacco smoking. An epidemiologic study. Dan Med Bull. 1992; 39(1):30-48. View

Xu X, Dockery D, Ware J, Speizer F, FERRIS Jr B . Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis. 1992; 146(5 Pt 1):1345-8. DOI: 10.1164/ajrccm/146.5_Pt_1.1345. View

10.

Toren K, Brisman J, Jarvholm B . Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest. 1993; 104(2):600-8. DOI: 10.1378/chest.104.2.600. View

11.

Anthonisen N, Connett J, Kiley J, Altose M, Bailey W, Buist A . Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994; 272(19):1497-505. View

12.

Murray C, Lopez A . Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349(9064):1498-504. DOI: 10.1016/S0140-6736(96)07492-2. View

13.

Krzyzanowski M, Jedrychowski W, Wysocki M . Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986; 134(5):1011-9. DOI: 10.1164/arrd.1986.134.5.1011. View

14.

Lindberg A, Jonsson A, Ronmark E, Lundgren R, Larsson L, Lundback B . Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest. 2005; 127(5):1544-52. DOI: 10.1378/chest.127.5.1544. View

15.

Vestbo J, Lange P . Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?. Am J Respir Crit Care Med. 2002; 166(3):329-32. DOI: 10.1164/rccm.2112048. View

16.

Mannino D, Homa D, Akinbami L, Ford E, Redd S . Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ. 2002; 51(6):1-16. View

17.

Anthonisen N, Connett J, Murray R . Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002; 166(5):675-9. DOI: 10.1164/rccm.2112096. View

18.

Mannino D, Buist A, Petty T, Enright P, Redd S . Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003; 58(5):388-93. PMC: 1746680. DOI: 10.1136/thorax.58.5.388. View

19.

Ezzati M, Lopez A . Estimates of global mortality attributable to smoking in 2000. Lancet. 2003; 362(9387):847-52. DOI: 10.1016/S0140-6736(03)14338-3. View

20.

Bergdahl I, Toren K, Eriksson K, Hedlund U, Nilsson T, Flodin R . Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J. 2004; 23(3):402-6. DOI: 10.1183/09031936.04.00034304. View